This study aimed to establish a clinical prediction model for assessing the degree of left atrial fibrosis (LAF) in patients with atrial fibrillation (AF) by combining two-dimensional speckle tracking echocardiography (2D-STE). Additionally, the study sought to evaluate the predictive utility of 2D-STE for left atrial appendage thrombosis (LAAT) and the recurrence of AF after radiofrequency catheter ablation (RFA). A total of 195 patients with AF were included, and late gadolinium enhanced cardiac magnetic resonance was adopted to assess LAF degree. Fibrotic tissue as a percentage of total left atrial wall volume > 20% was defined as severe LAF. Echocardiographic parameters were obtained and analyzed using 2D-STE. The patients were randomly divided into two cohorts (7:3) as the training and testing cohorts. Independent predictors of severe LAF were determined via univariate and multivariate logistic regression, including age, CHADS-VA score, left atrial appendage emptying fraction (LAA-EF), peak atrial longitudinal strain (PALS), left atrial stiffness index (LASI), left atrial strain during contraction phase (LASct) and left atrial strain during conduit phase (LAScd). The nomogram was established with the above variables and the area under the curve of the nomogram in testing cohorts was 0.89 (95% CI, 0.80-0.98). As validated by receiver operating characteristic curves, calibration curves and decision curve analysis, the nomogram model demonstrated promising potential for clinical application. Besides, by univariate and multivariate logistic regression analyses, CHADS-VA score, uric acid, LAA-EF, left atrial appendage peak blood flow emptying velocity (LAA-PEV) and LASct were found to be independent predictors of LAAT, and left atrial appendage length, E/e' and LASct were found to be independent predictors of post-ablation AF recurrence. 2D-STE can be applied to evaluate LAF degree of AF patients and predict LAAT and AF recurrence.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10554-025-03345-6DOI Listing

Publication Analysis

Top Keywords

left atrial
40
atrial appendage
16
atrial
13
independent predictors
12
left
10
two-dimensional speckle
8
speckle tracking
8
tracking echocardiography
8
atrial fibrosis
8
atrial fibrillation
8

Similar Publications

Aims: Whether the intraprocedural anticoagulation regimen and activated clotting time (ACT) in pulsed field ablation (PFA) for atrial fibrillation (AF) are the same as those for radiofrequency catheter ablation (RFCA) is currently unknown.

Methods And Results: Our retrospective study included 51 paroxysmal AF patients who underwent PFA (PFA group) and were matched with paroxysmal AF patients who underwent RFCA. Nearest-neighbor propensity score matching was performed at a 1:1 ratio (no tolerance to anticoagulant regimens and a tolerance of 0.

View Article and Find Full Text PDF

Background: In heart failure (HF) patients with a higher left ventricular ejection fraction (LVEF), the B-type natriuretic peptide (BNP) level is yet to be fully assessed. Accordingly, we hypothesized that the BNP level should be higher in patients with a higher LVEF range based on the previous finding that such patients were associated with a worse prognosis.

Methods And Results: In our multicenter, prospective, observational cohort for the composite endpoint of all-cause death and readmission due to HF, including patients with LVEF >40% at hospital discharge, we obtained LVEF, E/e', and BNP levels in 231 patients.

View Article and Find Full Text PDF

Heart failure with preserved ejection fraction (HFpEF) is a major subtype of heart failure, primarily characterized by a normal or mildly reduced left ventricular ejection fraction along with left ventricular diastolic dysfunction. Recent studies have shown that the prevalence of HFpEF is higher in women than that in men, particularly in postmenopausal women. Concurrently, it has been observed that the incidence of risk factors contributing to HFpEF (such as obesity, hypertension, diabetes, and atrial fibrillation) also notably increases post-menopause, affecting the incidence of HFpEF.

View Article and Find Full Text PDF

CLINICAL RISK PREDICTORS FOR ABNORMAL LEFT VENTRICULAR AND ATRIAL FUNCTION IN LUPUS ERYTHEMATOSUS.

J Am Soc Echocardiogr

March 2025

Cardiovascular Division and Robert M. Berne Cardiovascular Research Center, University of Virginia, Charlottesville, VA. Electronic address:

Background: In systemic lupus erythematosus (SLE), ventricular dysfunction can occur from primary immune injury or secondarily from SLE-related co-morbidities. The aim of this study was to determine clinical predictors of reduced left ventricular (LV) systolic and diastolic function in an effort to understand potentially mitigating strategies.

Methods: We retrospectively studied 76 patients with SLE who had comprehensive transthoracic echocardiography within 3 months of an appointment with a rheumatologist to correlate clinical, laboratory, and echocardiographic features.

View Article and Find Full Text PDF

This study aimed to establish a clinical prediction model for assessing the degree of left atrial fibrosis (LAF) in patients with atrial fibrillation (AF) by combining two-dimensional speckle tracking echocardiography (2D-STE). Additionally, the study sought to evaluate the predictive utility of 2D-STE for left atrial appendage thrombosis (LAAT) and the recurrence of AF after radiofrequency catheter ablation (RFA). A total of 195 patients with AF were included, and late gadolinium enhanced cardiac magnetic resonance was adopted to assess LAF degree.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!